Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial

BACKGROUND: To assess the efficacy and safety of a metronomic schedule of oral vinorelbine (mVNR) in advanced non-small-cell lung cancer (NSCLC) in patients unfit for platinum-based combination chemotherapy. PATIENTS AND METHODS: This was a multicenter, prospective, randomized, open-label phase II s...

Descripción completa

Detalles Bibliográficos
Autores principales: Camerini, A., Morabito, A., Montanino, A., Bernabé, R., Grossi, F., Ramlau, R., Ciuleanu, T.-E., Ceresoli, G.-L., Pasello, G., de Marinis, F., Bosch-Barrera, J., Laundreau, P., Gautier, S., Ta Thanh Minh, C., Kowalski, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903063/
https://www.ncbi.nlm.nih.gov/pubmed/33611164
http://dx.doi.org/10.1016/j.esmoop.2021.100051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903063/
https://www.ncbi.nlm.nih.gov/pubmed/33611164
http://dx.doi.org/10.1016/j.esmoop.2021.100051

Ejemplares similares